CB Arbitrage Desk Refinitiv · LSEG Eikon updated 2026-05-17 08:07
DEMO MODE · Static snapshot. The live version (running locally) pulls fresh Refinitiv data every weekday at 08:04. View code on GitHub.
← back to universe

Nxera Pharma

JP271701055= · underlying 4565.T · matures 2028-12-14
NR 429bp MODEL_NO_FIT View memo →
Plain-English summary This bond looks cheap to model by +31.4%. The market is paying 81.75 (% of par) while our pricer says fair value is 107.39. To trade it: buy ¥100M face, short delta × shares of 4565.T to neutralize stock direction, hold until the gap closes (typical: 1-3 months). Greeks below show how the bond responds to changes in stock price, vol, time, and interest rates — these drive your hedge ratios.
Market81.75
Model · Tree107.39
Cheap+31.4%
Bond floor86.81
Parity65.77
Premium24%
HV6065%
IV
Δ Delta0.031
Γ Gamma-0.00000
Vega0.39
θ /day-0.002

Position sizing & hedge calculator

Bond cost (mkt)
Shares to short
Short proceeds
Expected mispricing
Theta /day
Vega /1 vol pt

Buy ¥100M face of this CB at market 81.75 = . Short shares of 4565.T at ¥1,172. If model is right, expected gross convergence P&L is . After 25bp bond round-trip + 5bp equity round-trip transaction costs, net edge is . At 1% JPY financing on the long bond, daily carry costs (offset by short rebate).

Price history — model vs market (backtest)

Cheap% over time (backtest)